Bay-y-1015
Bay-y-1015 is an orally active quinoline-based 5-lipoxygenase inhibitor. Bay-y-1015 inhibits LTB4 and LTC4 synthesis. Bay-y-1015 can be used in the research of inflammatory diseases[1].
Product Specifications
CAS Number
133012-05-2
UNSPSC
12352005
Target
Lipoxygenase
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Inflammation/Immunology
Smiles
O=C(NS(=O)(C)=O)[C@H](C1CCCCCC1)C(C=C2)=CC=C2OCC3=NC4=CC=CC=C4C=C3
Molecular Formula
C26H30N2O4S
Molecular Weight
466.59
References & Citations
[1]Cunningham FM, et al. Pharmacology of the 5-lipoxygenase inhibitors BAY Y 1015 and BAY X 1005 in the horse. J Vet Pharmacol Ther. 1997 Aug;20 (4) :296-307.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
5-LOX
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC402298-500 1x 500 µL
Cytokeratin 8/18 (rKRT8.18/1346), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
